Arthur L. Edge III – As an Associate Director, Global Technical Operations at AstraZeneca (AZ), Arthur is a Product Champion, pushing the boundaries of science to deliver life-changing medicines. His focus is on strengthening AstraZeneca’s manufacturing strategy and leading the launch of new products in a fight to eliminate severe asthma and COVID-19. Prior to AZ, Arthur developed a broad array of experiences supporting advancements in medicine and technology. While at GlaxoSmithKline (GSK), he built robust manufacturing processes to ensure patients never run out of the first drug approved to treat lupus. At Emergent BioSolutions, he created new vaccines and therapies to help the US Government quickly respond to Zika and Ebola outbreaks. And in search of renewable energy sources at DSM, he designed biofuels from algae, which BMW leveraged at the 2012 Olympics in London to power its low-emission vehicle fleet.
Arthur is also active in the scientific community, leading workforce development initiatives and big data think tanks with the National Institute for Innovation in Manufacturing of Biopharmaceuticals (NIIMBL). He supports the National Society of Black Engineers (NSBE) as Director of the Healthcare Innovation Special Interest Group and his past NSBE service includes being President of the Washington DC Professionals chapter, named “2012 Chapter of the Year”. Finally, Arthur is an advisory board member for both George Mason University's Bioengineering Alliance and the International Society for Pharmaceutical Engineering (ISPE), while also being an ambassador for the Smithsonian National Museum of African American History and Culture (NMAAHC).
Arthur holds a Bachelor of Chemical Engineering (University of Michigan) and Master of Chemical and Biomolecular Engineering (Johns Hopkins University). During his free time, he "shakes it up" with salsa and swing dance teams in Washington, DC.